Hematologic Disorder: Clinical Trials

2 trials for Hematologic Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow Hematologic Disorder: new trials by email Literature Review of Hematologic Disorder trials Research Report on Hematologic Disorder

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy
Naderin, AC Chemotherapy - Breast Cancer, Hematologic Disorder
Phase 2 / Phase 3CompletedMIPO Clinic792014-01-012026-06-30
Dexamethasone Dyspnea Study
Dexamethasone, Placebo, Questionnaires - Advanced Cancers, Hematologic Disorder
Phase 2CompletedM.D. Anderson Cancer Center522013-01-012021-02-17

Narrower conditions

Hematologic Diseases (2)  ·  Breast Neoplasms (1)  ·  Dyspnea (1)  ·  Leukopenia (1)

Broader conditions

Hemic and Lymphatic Diseases (2)  ·  Breast Diseases (1)  ·  Cytopenia (1)  ·  Leukocyte Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Respiratory (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Calcium Dobesilate (1)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Doxorubicin (1)  ·  Sugars (1)  ·  Surveys and Questionnaires (1)  ·  sodium nucleinate (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  MIPO Clinic (1)

Countries

United States (1)

Top investigators

David Hui, MD (1)

Results publications

PMID 27330023